Literature DB >> 23489648

Pulmonary vein isolation using a second-generation cryoballoon catheter: a randomized comparison of ablation duration and method of deflation.

Jason G Andrade1, Marc Dubuc, Peter G Guerra, Evelyn Landry, Nicolas Coulombe, Hugues Leduc, Léna Rivard, Laurent Macle, Bernard Thibault, Mario Talajic, Denis Roy, Paul Khairy.   

Abstract

INTRODUCTION: Optimal cryoballoon ablation parameters for pulmonary vein (PV) isolation remain to be defined. We conducted a randomized preclinical trial to compare 2- versus 4-minute ablation lesions and assess the safety of active (forced) cryoballoon deflation. METHODS AND
RESULTS: Thirty-two dogs underwent PV isolation with a second-generation 23 mm cryoballoon catheter. The left superior (LSPV) and inferior (LIPV) PVs were randomized in a factorial design to (1) a single 2- versus 4-minute cryoapplication, and (2) passive versus active cryoballoon deflation. Animals were survived for 30 days, after which histopathologic analysis was performed. Acute PV isolation was attained in 89.8% of PVs after a single application (93.8% LSPV, 85.2% LIPV; P = 0.2823). Mean time to PV isolation was 29.5 ± 18.5 seconds. Although 4-minute lesions were associated with a thicker neointima than 2-minute lesions (223.8 μm versus 135.6 μm; P = 0.007), no differences were observed in procedural characteristics (freezing temperature, rewarming time), rates of acute PV isolation, or the achievement of complete circumferentially transmural lesions at 30 days (78.7% overall; 86.2% for 2 minutes vs 70.0% for 4 minutes; P = 0.285). Active deflation was associated with faster balloon rewarming but not with significant differences in mean or maximum neointimal thickness.
CONCLUSION: A single application with the second-generation cryoballoon catheter results in a high rate of PV isolation. The degree of vascular injury was not increased by active balloon deflation and no differences in acute efficacy or mature transmural circumferential lesions were observed with 2- versus 4-minute applications.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23489648     DOI: 10.1111/jce.12114

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  18 in total

1.  Improved visualisation of real-time recordings during third generation cryoballoon ablation: a comparison between the novel short-tip and the second generation device.

Authors:  Giacomo Mugnai; Carlo de Asmundis; Burak Hünük; Erwin Ströker; Darragh Moran; Ebru Hacioglu; Diego Ruggiero; Jan Poelaert; Christian Verborgh; Vincent Umbrain; Stefan Beckers; Hugo Enrique Coutino-Moreno; Ken Takarada; Valentina de Regibus; Pedro Brugada; Gian-Battista Chierchia
Journal:  J Interv Card Electrophysiol       Date:  2016-02-12       Impact factor: 1.900

2.  Quantitative assessment of a second-generation cryoballoon ablation catheter with new cooling technology-a perspective on potential implications on outcome.

Authors:  Sven Knecht; Michael Kühne; Stefan Osswald; Christian Sticherling
Journal:  J Interv Card Electrophysiol       Date:  2014-03-14       Impact factor: 1.900

3.  Cryoballoon Ablation in Today's Practice: Can the Left Common Ostium Be Ablated and Injury to the Right Phrenic Nerve Avoided?

Authors:  Gian-Battista Chierchia; Saverio Iacopino; Carlo de Asmundis
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-12

4.  Outcome of paroxysmal atrial fibrillation ablation with the cryoballoon using two different application times: the 4- versus 3-min protocol.

Authors:  Florian Straube; Uwe Dorwarth; Stefan Hartl; Benedikt Bunz; Michael Wankerl; Ullrich Ebersberger; Ellen Hoffmann
Journal:  J Interv Card Electrophysiol       Date:  2015-12-23       Impact factor: 1.900

5.  Long-Term Evolution of Patients Treated for Paroxysmal Atrial Fibrillation with First and Second Generation Cryoballoon Catheter Ablation with a Prospective Protocol Guided by Complete Bidirectional Left Atrium-Pulmonary Veins Disconnection after Adenosine as Main Target end Point to achieved. Seven Years Follow-up of Patients with a rough estimation profile of Low ALARMEc Score. A Single Center Report.

Authors:  Jesus M Paylos; Aracelis Morales; Luis Azcona; Marisol Paradela; Raquel Yagüe; Fernando Gómez-Guijarro; Lourdes Lacal; R N Clara Ferrero; Octavio Rodríguez
Journal:  J Atr Fibrillation       Date:  2016-04-30

6.  Initial experience of three-minute freeze cycles using the second-generation cryoballoon ablation: acute and short-term procedural outcomes.

Authors:  Gian-Battista Chierchia; Giacomo Di Giovanni; Juan Sieira-Moret; Carlo de Asmundis; Giulio Conte; Moises Rodriguez-Mañero; Ruben Casado-Arroyo; Giannis Baltogiannis; Gaetano Paparella; Giuseppe Ciconte; Andrea Sarkozy; Pedro Brugada
Journal:  J Interv Card Electrophysiol       Date:  2013-12-07       Impact factor: 1.900

7.  Real-Time MRI-Guided Cardiac Cryo-Ablation: A Feasibility Study.

Authors:  Eugene G Kholmovski; Nicolas Coulombe; Joshua Silvernagel; Nathan Angel; Dennis Parker; Rob Macleod; Nassir Marrouche; Ravi Ranjan
Journal:  J Cardiovasc Electrophysiol       Date:  2016-03-21

Review 8.  Complications of Atrial Fibrillation Cryoablation.

Authors:  Ugur Canpolat; Duygu Kocyigit; Kudret Aytemir
Journal:  J Atr Fibrillation       Date:  2017-12-31

Review 9.  Outcomes Of Cryoballoon Ablation Of Atrial Fibrillation: A Comprehensive Review.

Authors:  Arash Aryana; Mark R Bowers; Padraig Gearoid O'Neill
Journal:  J Atr Fibrillation       Date:  2015-08-31

10.  Single freeze strategy with the second- generation cryballoon for atrial fibrillation: a multicenter international retrospective analysis in a large cohort of patients.

Authors:  Valentina De Regibus; Saverio Iacopino; Juan Pablo Abugattas; Hugo Enrique Coutiño; Giacomo Mugnai; Cesare Storti; Giulio Conte; Angelo Auricchio; Darragh Moran; Erwin Ströker; Luis Marroquin; Ken Takarada; Rajin Choudhury; Carlo de Asmundis; Pedro Brugada; Gian-Battista Chierchia
Journal:  J Interv Card Electrophysiol       Date:  2017-06-01       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.